Olema Pharmaceuticals, Inc. OLMA Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s stock issuance proceeds?
- Olema Pharmaceuticals, Inc. (OLMA) reported stock issuance proceeds of $8.43M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?
- Olema Pharmaceuticals, Inc.'s stock issuance proceeds increased by 3472.0% year-over-year, from $236K to $8.43M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s stock issuance proceeds?
- Over 3 years (2022 to 2025), Olema Pharmaceuticals, Inc.'s stock issuance proceeds has grown at a 285.9% compound annual growth rate (CAGR), from $146K to $8.39M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.